Small molecules that treat or prevent viral infections
AssigneeUniversity of Houston System
InventorsBradley K. McConnell, Arfaxad Reyes Alcaraz, John W. Craft, Robert J. Schwartz
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Houston System
InventorsBradley K. McConnell, Arfaxad Reyes Alcaraz, John W. Craft, Robert J. Schwartz
Estimating the term…
Embodiments of the present disclosure pertain to anti-viral compounds suitable for use in blocking virus entry into cells. Further embodiments of the present disclosure pertain to methods of blocking virus entry into cells by associating the cells with at least one anti-viral compound of the present disclosure. In some embodiments, the associating occurs in vitro. In some embodiments, the associating occurs in vivo in a subject through administration of the at least one anti-viral compound to the subject. Additional embodiments of the present disclosure pertain to methods of treating or preventing a viral infection in a subject by administering to the subject at least one anti-viral compound of the present disclosure. In some embodiments, the subject is a human being suffering from or vulnerable to the viral infection. In some embodiments, the virus includes a coronavirus, such as severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2).
A method of treating or preventing a viral infection in a subject, said method comprising:
Dependencies are inferred from the claim text.